Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Virtual Booth

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

DIGITAL CONTENT

2 NEWS #PharmaBuzz

media
2 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

1DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Lcq-908, 956136-95-1, Lcq908, Pradigastat free acid, Lcq-908nxa, Lcq908-nxa

Molecular Formula

C₂₅H₂₄F₃N₃O₂

Molecular Weight

455.5 g/mol

InChI Key

GXALXAKNHIROPE-UHFFFAOYSA-N

FDA UNII

2U23G6VNUZ

Pradigastat has been used in trials studying the treatment of Non-alcoholic Fatty Liver Disease (NAFLD).

1 2D Structure

Pradigastat

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-[4-[4-[5-[[6-(trifluoromethyl)pyridin-3-yl]amino]pyridin-2-yl]phenyl]cyclohexyl]acetic acid

2.1.2 InChI

InChI=1S/C25H24F3N3O2/c26-25(27,28)23-12-10-21(15-30-23)31-20-9-11-22(29-14-20)19-7-5-18(6-8-19)17-3-1-16(2-4-17)13-24(32)33/h5-12,14-17,31H,1-4,13H2,(H,32,33)

2.1.3 InChI Key

GXALXAKNHIROPE-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1CC(CCC1CC(=O)O)C2=CC=C(C=C2)C3=NC=C(C=C3)NC4=CN=C(C=C4)C(F)(F)F

2.2 Other Identifiers

2.2.1 UNII

2U23G6VNUZ

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Lcq908

2.3.2 Depositor-Supplied Synonyms

1. Lcq-908

2. 956136-95-1

3. Lcq908

4. Pradigastat Free Acid

5. Lcq-908nxa

6. Lcq908-nxa

7. Lcq-908-nxa

8. 2u23g6vnuz

9. Lcq908 - Dgat-1-inhibitor

10. 956136-95-1 (free Acid)

11. Pradigastat (usan)

12. Lcq 908

13. Pradigastat [usan]

14. 2-((1s,4s)-4-(4-(5-((6-(trifluoromethyl)pyridin-3-yl)amino)pyridin-2-yl)phenyl)cyclohexyl)acetic Acid

15. 2-[4-[4-[5-[[6-(trifluoromethyl)pyridin-3-yl]amino]pyridin-2-yl]phenyl]cyclohexyl]acetic Acid

16. 2-{4-[4-(5-{[6-(trifluoromethyl)pyridin-3-yl]amino}pyridin-2-yl)phenyl]cyclohexyl}acetic Acid

17. Pradigastat [inn]

18. Pradigastat [usan:inn]

19. Unii-2u23g6vnuz

20. Lcq 908nxa

21. Schembl180536

22. Gtpl7830

23. Schembl1289309

24. Chembl2364624

25. Schembl16104874

26. Schembl18286769

27. Dtxsid401026085

28. Bcp21089

29. Lcq908; Lcq 908; Pradigastat

30. Bdbm50502586

31. Zinc253387875

32. Cs-1222

33. Db12866

34. Sb16971

35. Ncgc00378933-01

36. Ncgc00378933-02

37. Hy-16278

38. Db-125833

39. D10664

40. A900338

41. Q27088438

42. (4-{4-[5-(6-trifluoromethyl-pyridin-3-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic Acid

43. Cyclohexaneacetic Acid, 4-(4-(5-((6-(trifluoromethyl)-3-pyridinyl)amino)-2-pyridinyl)phenyl)-, Trans-

44. Lcq-908; Trans-4-[4-[5-[[6-(trifluoromethyl)-3-pyridinyl]amino]-2-pyridinyl]phenyl]cyclohexaneacetic Acid;lcq-908

45. Trans-4-[4-[5-[[6-(trifluoromethyl)-3-pyridinyl]amino]-2-pyridinyl]phenyl]cyclohexaneacetic Acid

2.4 Create Date

2011-10-17

3 Chemical and Physical Properties

Molecular Formula	C₂₅H₂₄F₃N₃O₂
Molecular Weight	455.5 g/mol
XLogP3	5.7
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	8
Rotatable Bond Count	6
Exact Mass	455.18206150 g/mol
Monoisotopic Mass	455.18206150 g/mol
Topological Polar Surface Area	75.1 Å²
Heavy Atom Count	33
Formal Charge	0
Complexity	631
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Indication

Treatment of familial chylomicronaemia syndrome (type I hyperlipoproteinaemia

Drugs in Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

ABOUT THIS PAGE

Find Pradigastat manufacturers, exporters & distributors on PharmaCompass

Pradigastat

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

DEVELOPMENTS

1 Drugs in Development

DIGITAL CONTENT

2 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

1DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?